Panagora Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,318
Closed -$1.34M 2835
2021
Q2
$1.34M Sell
7,318
-807
-10% -$148K 0.01% 876
2021
Q1
$1.24M Sell
8,125
-34
-0.4% -$5.2K 0.01% 932
2020
Q4
$1.28M Sell
8,159
-12,411
-60% -$1.94M 0.01% 873
2020
Q3
$2.35M Sell
20,570
-91
-0.4% -$10.4K 0.01% 576
2020
Q2
$2.32M Buy
20,661
+320
+2% +$35.9K 0.01% 614
2020
Q1
$1.83M Sell
20,341
-1,740
-8% -$156K 0.01% 621
2019
Q4
$2.39M Sell
22,081
-142,152
-87% -$15.4M 0.01% 718
2019
Q3
$16.1M Buy
164,233
+140,594
+595% +$13.8M 0.07% 247
2019
Q2
$3.1M Sell
23,639
-70,221
-75% -$9.2M 0.01% 655
2019
Q1
$12.7M Buy
93,860
+86,899
+1,248% +$11.7M 0.06% 308
2018
Q4
$678K Sell
6,961
-71,066
-91% -$6.92M ﹤0.01% 1235
2018
Q3
$10.8M Sell
78,027
-3,209
-4% -$446K 0.04% 348
2018
Q2
$10.1M Sell
81,236
-11,415
-12% -$1.42M 0.04% 347
2018
Q1
$10.3M Buy
92,651
+83,677
+932% +$9.33M 0.04% 355
2017
Q4
$1.07M Sell
8,974
-6,013
-40% -$719K ﹤0.01% 1111
2017
Q3
$2.1M Buy
14,987
+5,515
+58% +$774K 0.01% 842
2017
Q2
$1.15M Buy
9,472
+812
+9% +$98.8K ﹤0.01% 1061
2017
Q1
$1.05M Sell
8,660
-1,125
-11% -$136K ﹤0.01% 1123
2016
Q4
$1.2M Sell
9,785
-1,304
-12% -$160K 0.01% 1126
2016
Q3
$1.36M Buy
11,089
+1,464
+15% +$179K 0.01% 1073
2016
Q2
$1.12M Buy
9,625
+451
+5% +$52.7K 0.01% 1083
2016
Q1
$1.28M Buy
9,174
+2,787
+44% +$388K 0.01% 1007
2015
Q4
$1.22M Sell
6,387
-380
-6% -$72.5K 0.01% 988
2015
Q3
$1.06M Sell
6,767
-987
-13% -$154K 0.01% 1020
2015
Q2
$1.4M Hold
7,754
0.01% 948
2015
Q1
$1.34M Sell
7,754
-915
-11% -$159K 0.01% 948
2014
Q4
$1.6M Buy
8,669
+612
+8% +$113K 0.01% 822
2014
Q3
$1.34M Sell
8,057
-1,607
-17% -$266K 0.01% 910
2014
Q2
$1.51M Sell
9,664
-9,845
-50% -$1.54M 0.01% 913
2014
Q1
$2.97M Buy
19,509
+6,147
+46% +$935K 0.01% 722
2013
Q4
$1.78M Buy
13,362
+1,130
+9% +$150K 0.01% 921
2013
Q3
$1.42M Sell
12,232
-9,027
-42% -$1.05M 0.01% 959
2013
Q2
$1.96M Buy
+21,259
New +$1.96M 0.01% 787